BioSpace News Archive

Feb. 24, 2020 21:05 UTC IRVINE, Calif.--( BUSINESS WIRE )-- Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Raymond James 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes Hotel in Orlando on Monday, March 2, 2020 at 1:05 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the audiocast will be available following the live presentatio

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, reported its financial results for the quarter and year ended December 31, 2019 and financial guidance for the year ending December 31, 2020.

Feb. 24, 2020 21:15 UTC Dexcom to Present at Cowen 40 th Annual Healthcare Conference SAN DIEGO--( BUSINESS WIRE )-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Cowen 40 th Annual Healthcare Conference in Boston, MA, on Monday, March 2, 2020, at 3:30 PM

Feb. 24, 2020 21:03 UTC Fourth Quarter Highlights Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patient monitoring app STIM onTrack 2.1 Fiscal Year 2019 Highlights Net sales of $460.0 million, an increase of 1.5% compared to prior year and 2.6% o

BURLINGTON, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will be presenting at the 41 st Annual Raymond James Institutional Investors Conference in Orlando, Florida. Michael Clayman, M.D., President and Chief Executive Officer, is scheduled to present at 11:35 a.m. ET on Monday, March 2, 2020. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexionth

Not for distribution to U.S. news wire services or dissemination in the United States.

Feb. 24, 2020 21:15 UTC Revenue of $229.9 million in the fourth quarter of 2019 increased 19.7% from revenue of $192.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%; Full year 2019 revenue of $861.0 million increased 22.2% from full year 2018. Net new business awards were $281.1 million in the fourth quarter of 2019, representing an increase of 21.6% from net new business awards of $231.2 million for the comparable prior-ye

The National Association of Chronic Disease Directors has published its annual white paper to promote investment in chronic disease prevention and health promotion.

Asymchem announced that manufacturing operations had resumed on February 10, 2020, one week after a government required extended New Year holiday due to the novel coronavirus outbreak.

MannKind Corporation announced that it will be featured as a presenting company at the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020 at 9:30 am at the Lotte New York Palace Hotel in New York, NY.